Valuation: Camurus AB

Market Cap 39.45B 3.97B 3.56B 3.29B 2.98B 5.58B 377B 5.65B 15.67B 198B 14.91B 14.59B 627B P/E 2026 *
41.8x
P/E 2027 * 28x
Enterprise Value 34.97B 3.52B 3.16B 2.92B 2.64B 4.94B 334B 5B 13.89B 175B 13.21B 12.93B 556B EV / Sales 2026 *
12.3x
EV / Sales 2027 * 9.06x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day+1.17%
1 week+0.15%
Current month+7.45%
1 month+6.42%
3 months+7.62%
6 months+27.81%
Current year+8.93%
1 week 657
Extreme 657
678.5
1 month 608
Extreme 608
678.5
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
710
3 years 323.6
Extreme 323.6
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 2002-12-31
Director of Finance/CFO 57 2025-06-30
Chief Tech/Sci/R&D Officer 58 2024-12-31
Director TitleAgeSince
Director/Board Member 63 2001-12-31
Chairman 77 2014-12-31
Director/Board Member 61 2020-05-06
Date Insider Type Main position Quantity % Market Cap. Importance
8/7/26 Sell

Executive/Senior Manager

-5,800 0.0096%
2/27/26 Sell

Chief Executive Officer

55,550 0.0928%
2/27/26 Sell

Chief Executive Officer

1,500 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
+1.28%+0.15%+9.11%+101.62% 3.97B
+0.22%-0.14%+55.12%+128.82% 1,143B
+0.91%+3.61%+41.21%+84.57% 647B
-0.12%-0.93%+25.59%+106.14% 506B
-1.17%+0.71%+51.21%+63.61% 384B
+0.86%-4.37%+61.16%+37.93% 350B
+0.16%+1.94%+30.82%+52.83% 293B
-0.62%+1.17%+2.87%+24.90% 265B
+0.75%+2.05%+53.85%+71.25% 242B
+0.25%+1.64%+32.05%+107.62% 197B
Average -0.03%+0.75%+36.30%+77.93% 403.15B
Weighted average by Cap. -0.20%+0.71%+42.88%+87.89%

Financials

2026 *2027 *
Net sales 2.85B 287M 258M 238M 216M 403M 27.28B 408M 1.13B 14.3B 1.08B 1.06B 45.35B 3.73B 375M 337M 311M 282M 527M 35.62B 533M 1.48B 18.67B 1.41B 1.38B 59.2B
Net income 948M 95.42M 85.64M 79.08M 71.71M 134M 9.06B 136M 377M 4.75B 358M 351M 15.07B 1.42B 143M 128M 118M 107M 200M 13.54B 203M 562M 7.1B 535M 524M 22.5B
Net Debt -4.49B -451M -405M -374M -339M -634M -42.88B -642M -1.78B -22.48B -1.69B -1.66B -71.27B -5.7B -574M -515M -476M -431M -806M -54.54B -816M -2.27B -28.59B -2.16B -2.11B -90.65B
Projected Income Statement - Annual - Camurus AB
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
26-10-28 SEK 671.00 +1.21% 28,707
26-10-27 SEK 663.00 -0.67% 73,992
26-10-26 SEK 667.50 +0.23% 50,306
26-10-23 SEK 666.00 -0.52% 49,592
26-10-22 SEK 669.50 -0.07% 78,976
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Camurus AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
663.00SEK
Average target price
807.25SEK
Spread / Average Target
+21.76%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Camurus AB
  1. Stock Market
  2. Stocks
  3. CAMX Stock